全文获取类型
收费全文 | 1249篇 |
免费 | 56篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 17篇 |
妇产科学 | 13篇 |
基础医学 | 32篇 |
口腔科学 | 81篇 |
临床医学 | 99篇 |
内科学 | 164篇 |
皮肤病学 | 7篇 |
神经病学 | 18篇 |
特种医学 | 16篇 |
外科学 | 59篇 |
综合类 | 355篇 |
一般理论 | 2篇 |
预防医学 | 187篇 |
眼科学 | 16篇 |
药学 | 95篇 |
3篇 | |
中国医学 | 89篇 |
肿瘤学 | 68篇 |
出版年
2024年 | 2篇 |
2023年 | 13篇 |
2022年 | 48篇 |
2021年 | 30篇 |
2020年 | 45篇 |
2019年 | 40篇 |
2018年 | 28篇 |
2017年 | 33篇 |
2016年 | 30篇 |
2015年 | 24篇 |
2014年 | 69篇 |
2013年 | 79篇 |
2012年 | 72篇 |
2011年 | 73篇 |
2010年 | 74篇 |
2009年 | 75篇 |
2008年 | 76篇 |
2007年 | 85篇 |
2006年 | 87篇 |
2005年 | 69篇 |
2004年 | 50篇 |
2003年 | 56篇 |
2002年 | 35篇 |
2001年 | 25篇 |
2000年 | 20篇 |
1999年 | 19篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 9篇 |
1995年 | 11篇 |
1994年 | 7篇 |
1993年 | 4篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 1篇 |
1988年 | 6篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有1325条查询结果,搜索用时 15 毫秒
961.
Megan Othus Aasthaa Bansal Lisel Koepl Samuel Wagner Scott Ramsey 《Value in health》2017,20(4):705-709
Background
Economic evaluations often measure an intervention effect with mean overall survival (OS). Emerging types of cancer treatments offer the possibility of being “cured” in that patients can become long-term survivors whose risk of death is the same as that of a disease-free person. Describing cured and noncured patients with one shared mean value may provide a biased assessment of a therapy with a cured proportion.Objective
The purpose of this article is to explain how to incorporate the heterogeneity from cured patients into health economic evaluation.Methods
We analyzed clinical trial data from patients with advanced melanoma treated with ipilimumab (Ipi; n = 137) versus glycoprotein 100 (gp100; n = 136) with statistical methodology for mixture cure models. Both cured and noncured patients were subject to background mortality not related to cancer.Results
When ignoring cured proportions, we found that patients treated with Ipi had an estimated mean OS that was 8 months longer than that of patients treated with gp100. Cure model analysis showed that the cured proportion drove this difference, with 21% cured on Ipi versus 6% cured on gp100. The mean OS among the noncured cohort patients was 10 and 9 months with Ipi and gp100, respectively. The mean OS among cured patients was 26 years on both arms. When ignoring cured proportions, we found that the incremental cost-effectiveness ratio (ICER) when comparing Ipi with gp100 was $324,000/quality-adjusted life-year (QALY) (95% confidence interval $254,000–$600,000). With a mixture cure model, the ICER when comparing Ipi with gp100 was $113,000/QALY (95% confidence interval $101,000–$154,000).Conclusions
This analysis supports using cure modeling in health economic evaluation in advanced melanoma. When a proportion of patients may be long-term survivors, using cure models may reduce bias in OS estimates and provide more accurate estimates of health economic measures, including QALYs and ICERs. 相似文献962.
The Cox proportional hazards cure model is a survival model incorporating a cure rate with the assumption that the population contains both uncured and cured individuals. It contains a logistic regression for the cure rate, and a Cox regression to estimate the hazard for uncured patients. A single predictive model for both the cure and hazard can be developed by using a cure model that simultaneously predicts the cure rate and hazards for uncured patients; however, model selection is a challenge because of the lack of a measure for quantifying the predictive accuracy of a cure model. Recently, we developed an area under the receiver operating characteristic curve (AUC) for determining the cure rate in a cure model (Asano et al., 2014), but the hazards measure for uncured patients was not resolved. In this article, we propose novel C-statistics that are weighted by the patients’ cure status (i.e., cured, uncured, or censored cases) for the cure model. The operating characteristics of the proposed C-statistics and their confidence interval were examined by simulation analyses. We also illustrate methods for predictive model selection and for further interpretation of variables using the proposed AUCs and C-statistics via application to breast cancer data. 相似文献
963.
Theresa Rossouw Joseph D. Tucker Gert U. van Zyl Kenly Sikwesi Catherine Godfrey 《Journal of the International AIDS Society》2017,20(1)
Introduction : HIV eradication and remission research has largely taken place in high‐income countries. In low‐ and middle‐income countries (LMIC), there may be factors that have a substantial impact on the size of the latent HIV reservoir and the immunological response to infection. If a curative strategy is to be available to all HIV‐infected individuals, these factors must be understood. Methods : We use a scoping review to examine the literature on biological factors that may have an impact on HIV persistence in LMIC. Three databases were searched without date restrictions. Results : Uncontrolled viral replication and higher coinfection prevalence may alter the immunological milieu of individuals in LMIC and increase the size of the HIV reservoir. Differences in HIV subtype could also influence the measurement and size of the HIV reservoir. Immune activation may differ due to late presentation to care, presence of chronic infections, increased gut translocation of bacterial products and poor nutrition. Conclusions : Research on HIV remission is urgently needed in LMIC. Research into chronic immune activation in resource poor environments, the immune response to infection, the mechanisms of HIV persistence and latency in different viral clades and the effect of the microbiological milieu must be performed. Geographic differences, which may be substantial and may delay access to curative strategies, should be identified. 相似文献
964.
D.J. Tinga J. Bouma H. Boonstra & J.G. Aalders 《International journal of gynecological cancer》1992,2(4):179-188
In a group of 367 women treated for invasive carcinoma of the cervix tumor recurrence was discovered at an asymptomatic stage in 16 (23%) patients. The tumor recurrence was localized to the pelvis in 29 (41%) cases, in the vaginal wall in 3 (4%) cases, and 39 (55%) patients had distant metastases (with or without recurrent tumor in the pelvis). Curative treatment (surgery, n = 2; radiotherapy, n = 8) was applied in 5/29 (17%) patients whose recurrent disease was confined to the pelvis, in all 3 patients with vaginal recurrence and in 2/39 (5%) of the patients with distant metastases. Permanent remission (follow-up > 36 months) was observed in 2 patients with vaginal recurrence and in one with central recurrence. Temporary complete remission (mean 22 months, range 12–30 months) was observed in 3 patients (2 with central recurrence and one with vaginal recurrence). In 20 (69%) of the patients with central or locoregional recurrence, the primary treatment had been so radical (including adjuvant postoperative or full radiotherapy) that surgical treatment or radiotherapy of the recurrence was not considered possible or worthwhile; moreover, 4 of the patients were older than 80 years of age. In retrospect, exenterative treatment could have been considered in 14 patients (< 70 years) and based on 50% operability, could have led to a cure in 2 to 4 patients with tumor recurrence in the pelvis without distant metastases. Chemotherapy was applied to 10 patients, one of whom went into complete remission of lung metastases (follow-up 108 months). 相似文献
965.
Single-dose methotrexate Combined with Chinese medicinal herbs treated unruptured and ruptured ectopic pregnancy
下载免费PDF全文
![点击此处可从《中国结合医学杂志》网站下载免费的PDF全文](/ch/ext_images/free.gif)
pregnancy(EP)hasbeenincreasingyearbyyear.Recently,variouskindsofmedicinesusedfortreatmentofEPhavebeenreported.Themethotrexate(MTX)isthecommonestone,whichhasbeenusedindifferentways,suchas.IIntramuscularorintravenousinjection('),oraladministration(2),injectionwithinthegestationalsacunderlaparoscopicandvaginalultrasonographicguidance(').WhenasmalldoseofMTXwasusedrepeatedly,sideeffectratecouldreach20%--30%(4).UPtonow,asfarasweknow,EPistreatedbyMTXdomesticallyorinternationallyonlyforunruptur… 相似文献
966.
Summary: A group of 55 patients were treated with 200 mg/day of ketoconazole. Infections treated:
- 1 P. versicolor 20 cases
- 2 Herpes circinatus (T. corporis) 10 cases
- 3 Eczema marginatum (T. inguinalis) 10 cases
- 4 Vulvo-vaginal candidosis (Candida vaginitis) 10 cases
- 5 Candidal intertrigo 5 cases
- 1 Pityriasis versicolor (20 Fälle)
- 2 Herpes circinatus (Tinea corporis) (10 Fälle)
- 3 Ekzema marginatum (Tinea inguinalis) (10 Fälle)
- 4 Vulvovaginitis candidomycetica (10 Fälle)
- 5 Candida-Intertrigo (5 Fälle).
967.
目的:通过分析我县1959-1997年丝虫防治效果,为以后丝防工作提供决策依据。方法:应用1959-1997年万载县丝载虫病防治资料进行分析。结果:1959年对载县进行丝虫病普查,发现我县仅有罗城、三兴、高村、鹅峰等四个乡(镇)有丝虫病的发生和流行。病原体为马来和斑氏丝虫、媒虫为中华按蚊及致乏库蚊,1959年丝虫病流行区感染率为3.2361%。经过对感染采用海群生群体防治措施,丝虫病感染率逐渐下降,1983年基本消来丝虫病,比过了省里验收,1990-1997年感染率已下降为0。说明我县以预防为主,加强丝虫病监测,采杉群防群治措施得力,结果明显,成绩显。但是今后仍应继续做好丝虫病的监测工作。 相似文献
968.
目的 :观察疏肝散结方治疗乳腺增生的临床疗效。方法 :自拟中药疏肝散结方内服。结果 :148例患者中 ,治愈 10 3例 ,显效 2 5例 ,有效 18例 ,无效 2例 ,总有效率 98%。结论 :疏肝散结方治疗乳腺增生 ,疗效确切 ,疗程较短 ,且无不良反应 ,值得临床推广应用。 相似文献
969.
Paul W. Bernhardt 《Statistics in medicine》2016,35(25):4607-4623
We propose a flexible cure rate model that accommodates different censoring distributions for the cured and uncured groups and also allows for some individuals to be observed as cured when their survival time exceeds a known threshold. We model the survival times for the uncured group using an accelerated failure time model with errors distributed according to the seminonparametric distribution, potentially truncated at a known threshold. We suggest a straightforward extension of the usual expectation–maximization algorithm approach for obtaining estimates in cure rate models to accommodate the cure threshold and dependent censoring. We additionally suggest a likelihood ratio test for testing for the presence of dependent censoring in the proposed cure rate model. We show through numerical studies that our model has desirable properties and leads to approximately unbiased parameter estimates in a variety of scenarios. To demonstrate how our method performs in practice, we analyze data from a bone marrow transplantation study and a liver transplant study. Copyright © 2016 John Wiley & Sons, Ltd. 相似文献
970.
目的:观察火针治疗痹证的临床疗效。方法:采用火针疗法治疗痹证175例进行疗效观察,同时设立了毫针对照组219例,结果:火针治疗组临床疗效优于毫针对照组,火针治疗组总治愈率及总有效率分别达到86.3%和97.7%,毫针对照组总治愈率及总有效率分别达到78.1%和94.1%,两组治疗“3次有效率”对比,两组“平均治愈时间”对比,火针治疗组明显优于毫针对照组(P<0.01),病程超过3年时,火针治疗组优于毫针对照组(P<0.05),3年以内则无显著性差异,结论:火针治疗痹症有显著而肯定的疗效。 相似文献